Stephen M. Spaethe

Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.

David J. Evans, Peter J. Barnes, Stephen M. Spaethe et al. · Thorax · 1996 · 177 citations · Full text

Pharmacologic Actions of the Second-Generation Leukotriene B4 Receptor Antagonist LY293111: In Vitro Studies

William T. Jackson, Larry L. Froelich, Robert J. Boyd et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 58 citations

A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media

Steven R. White, Giorgio V.P. Kulp, Stephen M. Spaethe et al. · Journal of Immunological Methods · 1991 · 57 citations

Allergy, Biochemistry, Lipid Peroxidation +7

Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Steven R. White, Mary E. Strek, Giorgio V.P. Kulp et al. · Journal of Clinical Investigation · 1993 · 54 citations · Full text

Asthma, Unique Granular Proteins, Inflammatory Lung Disease +22

Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist

Philip Marder, J. Scott Sawyer, Larry L. Froelich et al. · Biochemical Pharmacology · 1995 · 52 citations

Inflammation, Anti-inflammatory, Benzoic Acid +8